|
US4741900A
(en)
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
|
AU584417B2
(en)
|
1985-04-01 |
1989-05-25 |
Lonza Group Ag |
Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
WO1987005330A1
(en)
|
1986-03-07 |
1987-09-11 |
Michel Louis Eugene Bergh |
Method for enhancing glycoprotein stability
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
ATE243754T1
(de)
|
1987-05-21 |
2003-07-15 |
Micromet Ag |
Multifunktionelle proteine mit vorbestimmter zielsetzung
|
|
US5892019A
(en)
|
1987-07-15 |
1999-04-06 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Production of a single-gene-encoded immunoglobulin
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
AU631545B2
(en)
|
1988-04-15 |
1992-12-03 |
Protein Design Labs, Inc. |
Il-2 receptor-specific chimeric antibodies
|
|
DE68921982T4
(de)
|
1988-06-14 |
1996-04-25 |
Cetus Oncology Corp |
Kupplungsmittel und sterisch gehinderte, mit disulfid gebundene konjugate daraus.
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
ZA902949B
(en)
|
1989-05-05 |
1992-02-26 |
Res Dev Foundation |
A novel antibody delivery system for biological response modifiers
|
|
DK0710719T3
(da)
|
1990-01-12 |
2007-07-09 |
Amgen Fremont Inc |
Frembringelse af xenogene antistoffer
|
|
US5314995A
(en)
|
1990-01-22 |
1994-05-24 |
Oncogen |
Therapeutic interleukin-2-antibody based fusion proteins
|
|
DE69127749T2
(de)
|
1990-03-20 |
1998-04-16 |
The Trustees Of Columbia University In The City Of New York, New York, N.Y. |
Chimäre antikörper mit rezeptor-bindenden liganden anstelle ihrer konstanten region
|
|
AU660297B2
(en)
|
1990-11-09 |
1995-06-22 |
Stephen D. Gillies |
Cytokine immunoconjugates
|
|
IE922437A1
(en)
|
1991-07-25 |
1993-01-27 |
Idec Pharma Corp |
Recombinant antibodies for human therapy
|
|
NZ255101A
(en)
|
1992-07-24 |
1997-08-22 |
Cell Genesys Inc |
A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor
|
|
US5837821A
(en)
|
1992-11-04 |
1998-11-17 |
City Of Hope |
Antibody construct
|
|
CA2149326C
(en)
|
1992-11-13 |
2007-04-17 |
Mitchell E. Reff |
Fully impaired consensus kozak sequences for mammalian expression
|
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
CA2116280A1
(en)
|
1993-03-05 |
1994-09-06 |
Marcy E. Macdonald |
Huntingtin dna, protein and uses thereof
|
|
EP1978033A3
(en)
|
1995-04-27 |
2008-12-24 |
Amgen Fremont Inc. |
Human antibodies derived from immunized xenomice
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
GB9524973D0
(en)
|
1995-12-06 |
1996-02-07 |
Lynxvale Ltd |
Viral vectors
|
|
US6255455B1
(en)
*
|
1996-10-11 |
2001-07-03 |
The Trustees Of The University Of Pennsylvania |
Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
|
|
AU737155B2
(en)
|
1997-03-14 |
2001-08-09 |
Biogen Idec Inc. |
Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
|
|
CA2290485C
(en)
|
1997-05-21 |
2008-08-05 |
Biovation Limited |
Method for the production of non-immunogenic proteins
|
|
ATE323288T1
(de)
|
1997-08-01 |
2006-04-15 |
|
Verfahren zur bestimmung von amyloid-ähnlichen fibrillen oder proteinaggregaten
|
|
WO2000030680A1
(en)
|
1998-11-23 |
2000-06-02 |
Idec Pharmaceuticals Corporation |
Tumor antigen-specific antibody-gp39 chimeric protein constructs
|
|
EP1051432B1
(en)
|
1998-12-08 |
2007-01-24 |
Biovation Limited |
Method for reducing immunogenicity of proteins
|
|
WO2001006989A2
(en)
*
|
1999-07-27 |
2001-02-01 |
Abgenix, Inc. |
Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders
|
|
US7858559B2
(en)
|
2000-11-17 |
2010-12-28 |
University Of Rochester |
In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
|
|
AU2002327164A1
(en)
|
2001-01-29 |
2002-12-09 |
Idec Pharmaceuticals Corporation |
Engineered tetravalent antibodies and methods of use
|
|
MXPA03006771A
(es)
|
2001-01-29 |
2004-05-05 |
Idec Pharma Corp |
Anticuerpos modificados y metodos de uso.
|
|
EP1392849B2
(en)
*
|
2001-02-15 |
2012-01-18 |
University Of Chicago |
Yeast screens for agents affecting protein folding
|
|
US20030157641A1
(en)
|
2001-11-16 |
2003-08-21 |
Idec Pharmaceuticals Corporation |
Polycistronic expression of antibodies
|
|
US7375194B2
(en)
*
|
2002-01-28 |
2008-05-20 |
California Institute Of Technology |
Antibodies that bind to an epitope on the Huntington's disease protein
|
|
AU2004239114B2
(en)
*
|
2003-05-14 |
2008-03-13 |
Japan Science And Technology Agency |
Inhibition of the expression of huntingtin gene
|
|
EP1664116A4
(en)
|
2003-08-22 |
2009-06-03 |
Biogen Idec Inc |
IMPROVED ANTIBODIES WITH CHANGED EFFECTOR FUNCTION AND MANUFACTURING METHOD THEREFOR
|
|
WO2005052002A2
(en)
|
2003-11-20 |
2005-06-09 |
Massachusetts Institute Of Technology |
Single-domain antibodies and uses thereof
|
|
PL2426143T3
(pl)
*
|
2007-01-05 |
2017-12-29 |
University Of Zurich |
Sposób zapewniania specyficznych wobec choroby cząsteczek wiążących i celów
|
|
US20090304590A1
(en)
*
|
2007-05-29 |
2009-12-10 |
Wyeth |
Therapeutic compositions and methods
|
|
US8022268B2
(en)
*
|
2007-06-11 |
2011-09-20 |
The University Of Zurich |
Transgenic animal model for alzheimer's disease
|
|
DK2370466T3
(en)
|
2008-12-19 |
2015-08-03 |
Univ Zuerich |
Humane anti-alpha-synuclein-autoantistoffer
|
|
ES2686550T3
(es)
|
2010-10-11 |
2018-10-18 |
Biogen International Neuroscience Gmbh |
Anticuerpos anti-tau humanos
|
|
WO2012080518A1
(en)
|
2010-12-17 |
2012-06-21 |
Neurimmune Holding Ag |
Human anti-sod1 antibodies
|
|
WO2012113775A1
(en)
|
2011-02-21 |
2012-08-30 |
University Of Zurich |
Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders
|
|
CA2842169A1
(en)
*
|
2011-07-20 |
2013-01-24 |
Medimmune Limited |
Anti-cxcr4 antibodies and methods of use
|
|
KR101961508B1
(ko)
|
2011-10-28 |
2019-03-25 |
바이오겐 인터내셔널 뉴로사이언스 게엠베하 |
Tdp-43 특이적 결합 분자
|
|
CN105531287B
(zh)
*
|
2013-05-29 |
2020-01-21 |
维拜昂公司 |
改变亨廷顿蛋白突变体降解的单链胞内抗体
|
|
AU2015286604B2
(en)
*
|
2014-07-10 |
2019-08-15 |
Hd Immune Gmbh |
Substances and methods for the use in prevention and/or treatment in Huntington's disease
|
|
US10053518B2
(en)
*
|
2014-07-10 |
2018-08-21 |
Affiris Ag |
Substances and methods for the use in prevention and/or treatment in Huntington's disease
|
|
AU2015295441B2
(en)
|
2014-07-29 |
2020-05-14 |
Neurimmune Holding Ag |
Human-derived anti-huntingtin (HTT) antibodies and uses thereof
|